PROM1 and glioblastoma: Holmberg-Olausson and colleagues provided evidence that human prominin-1 may constitute a tumor cell-intrinsic marker independent of stem cell properties, as they observed a variability of prominin-1 expression levels in human glioblastoma, where higher prominin-1 expression correlated with shorter patient survival (21).